CARL ALLEN to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications CARL ALLEN has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.220
-
Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT. Blood Adv. 2023 07 25; 7(14):3725-3734.
Score: 0.104
-
A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer. 2017 Sep 01; 123(17):3229-3240.
Score: 0.068
-
Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. Pediatr Blood Cancer. 2013 Jan; 60(1):101-9.
Score: 0.048